Others have used antibody as a surrogate measure of antigen-specific anti-tumor immunity [4–6], and we hypothesized that IgG antibody signals would be more likely to overlap with features of antigen-specific CD8+ T cell recognition than expected by chance. The gene discussed is CD8A; the disease is neoplasm.